1 / 16

Molecular Light Technology

Molecular Light Technology. MLT Research Limited 5 Chiltern Close Cardiff Industrial Park CF14 5DL www.mltresearch.com. Stuart Woodhead. The Invention. Why Sensitivity?. 100,000,000,000,000,000,000------- 10,000,000,000,000,000,000------- 1,000,000 000 000,000,000-------

Télécharger la présentation

Molecular Light Technology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Molecular Light Technology MLT Research Limited 5 Chiltern Close Cardiff Industrial Park CF14 5DL www.mltresearch.com Stuart Woodhead

  2. The Invention

  3. Why Sensitivity? 100,000,000,000,000,000,000------- 10,000,000,000,000,000,000------- 1,000,000 000 000,000,000------- 100,000,000,000,000,000------- 10,000,000,000,000,000------- 1,000,000,000,000,000------- 100,000,000,000,000------- 10,000,000,000,000------- 1,000,000,000,000------- 100,000,000,000------- 10,000,000,000------- 1,000,000,000------- 100,000,000------- 10,000,000------- 1,000,000------- 1020 1019 1018 1017 1016 1015 1014 1013 1012 1011 1010 109 108 107 106 Legal limit (UK) Glucose Alcohol Lethal dose amatoxin Tumour antigens Hormones Viruses

  4. Milestones • 1977 Project started • 1978 First patent application • 1982 Synthesis of acridinium label • 1984 Measurement of TSH • 1986 First commercial immunoassay • 1989 First commercial probe assay • 1991 Launch of ACS-180 • 1997 Centaur • 2001 Blood Bank tests • 2003 TIGRIS

  5. Company History • 1988 MLT incorporated • 1991 First premises - main activity contract R & D • 1992 Started manufacturing • 1996 Acquired funding • 1997 Business strategy developed • TCS programme to monitor specific gene expression • 1998 Licensing of genetic probe technology • The Move • Implementation of new technology • First gene expression test launched • 2003 Acquisition by Gen-Probe

  6. Molecular Light Technology Year 1995 1998 2000 2002 No of Staff 7 12 15 25 Turnover 812 2,068 3,113 4,000 (thousands)

  7. Purpose of the Business • To become a major supplier of high technology tests for industrial, pharmaceutical and toxicological applications. • To achieve recognition as a centre of excellence for the development of intellectual property, novel technologies and products. • To maintain profitable growth and create long term value for all stakeholders.

  8. Growing the Business • Protecting the technology • Finding the right people to work with • Understanding clearly roles and responsibilities • Knowledge transfer • Knowing when to stop

  9. Intellectual Property • High value • Patent costs • Patent prosecution • Licensing • Infringement • Litigation

  10. Product Development • Scale up from prototype • Documentation • Raw materials • Validation • Quality control

  11. The Products • Immunoassays for diabetes research (proinsulin) • Gene-based assays for toxicological investigation (CYP) • Assays for enzymes involved in viral/bacterial replication (ligase, helicase, primase etc)

  12. mRNA AE AE-probe AE Protection Hydrolysis Hybridisation Protection Assay (HPA) Target Gene No Light

  13. Cell Suspension Treated with Benzopyrene

  14. The Future • Human toxicology • Hepatotoxicity • Neurotoxicity • Chemical carcinogenesis • Drug discovery • Food and water microbiology

  15. New Intellectual Property • 8 patents filed since 1997 • Genetic Biosensors • Drug discovery • Fuel marking • Chemiluminescent beacons

  16. The Lessons • Patent where possible • Develop educated conviction • Be persistent • Have a strategy • Continue to innovate • Learn from mistakes

More Related